Atricure Inc (ATRC) USD0.001
Sell:$13.34Buy:$41.00
$0.35
(1.04%)
- This stock can be held in a
Stocks and Shares ISA$0.35
(1.04%)$0.35
(1.04%)Company Information
About this company
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Key people
Key facts
- EPICATRC
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS04963C2098
- Market cap$1.61bn
- Employees1,300
- Shares in issue49.49m
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.